A fusion gene breakpoint cluster region (BCR)-ABL1 is commonly associated with chronic myeloid leukemia (CML) and a subset of acute lymphoblastic leukemia (ALL). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.